Patients who undergo echocardiography
Conditions
Interventions
None listed
Sponsors
Juntendo University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adults aged 20 years or older who underwent transthoracic echocardiography in the physiological examination department of our hospital between April 1, 2023, and September 30, 2023, and who did not meet any of the exclusion criteria.
Exclusion criteria
Exclusion criteria: Patients whose echocardiographic data are unavailable or inadequate for analysis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number and prevalence of patients who were screened as having HCM by AI-based echocardiographic analysis software (US2.ai) but were not clinically identified as HCM based on manual echocardiographic measurements and past medical records. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome 1: The number of patients clinically identified as having HCM and those not identified, based on manual echocardiographic measurements and past medical records. Secondary outcome 2: The number of patients identified as HCM by AI-based echocardiographic analysis and their clinical characteristics. Secondary outcome 3: The number of patients clinically identified as having HCM based on manual echocardiographic measurements and past medical records, along with their clinical characteristics. Secondary outcome 4: The clinical characteristics of patients identified as HCM by AI-based analysis but not by manual echocardiographic measurements. Secondary outcome 5: Clinical performance of the AI-based analysis in diagnosing HCM, including positive predictive value, sensitivity, and specificity. Secondary outcome 6: Accuracy of AI-based analysis in measuring echocardiographic parameters related to cardiac hypertrophy. | — |
Countries
Japan
Contacts
Public ContactNobuyuki Kagiyama
Juntendo University Hospital Department of Cardiovascular Biology and Medicine
Outcome results
None listed